HEPAMERZ INFUSION is a prescription formulation containing L-ornithine L-aspartate, used as supportive therapy in the management of liver-related conditions associated with elevated ammonia levels. It helps support the body's natural processes involved in ammonia metabolism and elimination. The formulation may be used in patients with hepatic encephalopathy or other liver disorders where ammonia accumulation is a concern. It is administered by intravenous infusion under the supervision of a qualified healthcare professional. The dosage and duration of treatment depend on the patient's clinical condition and the treating physician's recommendation. HEPAMERZ INFUSION should be used carefully in patients with severe kidney impairment unless specifically advised by a doctor. Possible adverse effects may include nausea, vomiting, abdominal discomfort, or other infusion-related reactions. It should be used only according to the prescribed instructions and appropriate medical monitoring. For pharmaceutical product availability and export inquiries, contact Phoenix Exim, an Indian pharmaceutical exporter.
